Business Description

Description
Adia Med Inc is engaged in clinical research in regenerative medicine by providing structured, transparent opportunities for individuals and families to participate in medically supervised investigational studies. Its therapies are Stem Cell Therapies, Platelet-Rich Plasma, AHSCT for MS, and Therapeutic Plasma Exchange.
Name Current Vs Industry Vs History
Cash-To-Debt
0.16
Equity-to-Asset
-0.54
Debt-to-Equity
-2.15
Debt-to-EBITDA
-2.88
Piotroski F-Score
N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-23.41
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
5-Day RSI
60.94
9-Day RSI
56.37
14-Day RSI
53.4
3-1 Month Momentum %
-16.67
6-1 Month Momentum %
-34.34
12-1 Month Momentum %
470.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.32
Quick Ratio
0.22
Cash Ratio
0.13
Days Inventory
68.98
Days Sales Outstanding
26.66
Days Payable
6.29

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-1.37

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
32.54
Operating Margin %
-54.18
Net Margin %
-58.57
EBITDA Margin %
-41.57
FCF Margin %
-28.95
OCF Margin %
-26.96
ROA %
-61.81
ROIC %
-51.73
ROC (Joel Greenblatt) %
-111.03
ROCE %
-115.88
Moat Score
1

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio
N/A
N/A
N/A
PE Ratio without NRI
N/A
N/A
N/A
PS Ratio
16.56
EV-to-EBIT
-36.61
EV-to-EBITDA
-47.37
EV-to-Revenue
19.69
EV-to-FCF
-68.01
Earnings Yield (Greenblatt) %
-2.73
FCF Yield %
-1.55

Financials

ADIA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ADIA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Adia Med Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.753
EPS (TTM) ($) -
Beta 0.9053
3-Year Sharpe Ratio 0.96
3-Year Sortino Ratio 3.67
Volatility % 236.42
14-Day RSI 53.4
14-Day ATR ($) 0.020358
20-Day SMA ($) 0.137351
12-1 Month Momentum % 470.37
52-Week Range ($) 0.025 - 0.27767
Shares Outstanding (Mil) 94.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adia Med Inc Filings

Filing Date Document Date Form
No Filing Data

Adia Med Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Adia Med Inc Frequently Asked Questions

What is Adia Med Inc(ADIA)'s stock price today?
The current price of ADIA is $0.15. The 52 week high of ADIA is $0.28 and 52 week low is $0.03.
When is next earnings date of Adia Med Inc(ADIA)?
The next earnings date of Adia Med Inc(ADIA) is .
Does Adia Med Inc(ADIA) pay dividends? If so, how much?
Adia Med Inc(ADIA) does not pay dividend.

Guru Commentaries on OTCPK:ADIA

No articles.

Press Release

Subject Date
No Press Release

Articles on Adia Med Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1